Paul G. Allen Family Foundation And Alzheimer’s Association Award Grants

Paul G. Allen Family Foundation And Alzheimer’s Association Award Grants
The Alzheimer's Association and the Paul G. Allen Family Foundation recently announced the award of three grants to assess the role of the immune system in Alzheimer's disease. The awards represent an investment of $500,000 to advance this understudied yet immense area of scientific knowledge, which could play a major role in the improved treatment and eventual cure of Alzheimer's disease. Alzheimer's disease affects the lives of 5.3 million people in the US alone and is the sixth leading cause of death in the country. The costs associated with Alzheimer's and other dementias, according to estimates, will reach $226 billion in 2015 and will increase to $1.1 trillion in 2050, as predicted by the Alzheimer's Association Facts and Figures report. "One of the largest obstacles to finding effective treatments for Alzheimer's is our lack of understanding of the basic biology of the disease, including the role of the immune system and inflammation. These projects closely examine the role that inflammation plays in Alzheimer's disease and carry the potential to reveal new therapies," noted Tom Skalak, the Executive Director for Science and Technology of the Paul G. Allen Family Foundation. Maria Carrillo, the Chief Science Officer of the Alzheimer's Association, added: "We know the stakes are high for finding lif
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *